Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gruber

Showing results (301-310 of 355) with videos related to

Pageof 36
Sort By:
Vaccine|February 8, 2022
Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trialStephen J Thomas, John L Perez, Stephen P Lockhart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)Anna M M van Deursen, Marlies A van Houten, Chris Webber, et al.
Infectious Diseases and Therapy|September 12, 2023
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in AdultsLouise Murdoch, Karen Quan, James A Baber, et al.
The Lancet. Infectious Diseases|September 6, 2020
Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trialJudith Absalon, Nathan Segall, Stan L Block, et al.
Human Vaccines & Immunotherapeutics|February 24, 2025
Safety, tolerability, and immunogenicity of pentavalent meningococcal MenABCWY vaccine in healthy infants: A phase 2b randomized clinical trialFederico Martinon-Torres, Erik Lamberth, Silvina Natalini Martinez, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 13, 2000
Esophageal dysplasias are detected by endoscopy with Lugol in patients at risk for squamous cell carcinoma in southern BrazilC P Freitag, S G Barros, C D Kruel, et al.
The Journal of Infectious Diseases|March 18, 2000
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccineR B Belshe, W C Gruber, P M Mendelman, et al.
The Pediatric Infectious Disease Journal|September 29, 2006
Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthmaDouglas M Fleming, Pietro Crovari, Ulrich Wahn, et al.
Vaccine|December 6, 2016
Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 studyRobert W Frenck, C Buddy Creech, Eric A Sheldon, et al.
The Journal of Pediatrics|February 5, 2000
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccineR B Belshe, W C Gruber, P M Mendelman, et al.
Pageof 36

Showing results (301-310 of 355) with videos related to

Sort By:
Pageof 36
Vaccine|February 8, 2022
Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trialStephen J Thomas, John L Perez, Stephen P Lockhart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)Anna M M van Deursen, Marlies A van Houten, Chris Webber, et al.
Infectious Diseases and Therapy|September 12, 2023
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in AdultsLouise Murdoch, Karen Quan, James A Baber, et al.
The Lancet. Infectious Diseases|September 6, 2020
Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trialJudith Absalon, Nathan Segall, Stan L Block, et al.
Human Vaccines & Immunotherapeutics|February 24, 2025
Safety, tolerability, and immunogenicity of pentavalent meningococcal MenABCWY vaccine in healthy infants: A phase 2b randomized clinical trialFederico Martinon-Torres, Erik Lamberth, Silvina Natalini Martinez, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 13, 2000
Esophageal dysplasias are detected by endoscopy with Lugol in patients at risk for squamous cell carcinoma in southern BrazilC P Freitag, S G Barros, C D Kruel, et al.
The Journal of Infectious Diseases|March 18, 2000
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccineR B Belshe, W C Gruber, P M Mendelman, et al.
The Pediatric Infectious Disease Journal|September 29, 2006
Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthmaDouglas M Fleming, Pietro Crovari, Ulrich Wahn, et al.
Vaccine|December 6, 2016
Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 studyRobert W Frenck, C Buddy Creech, Eric A Sheldon, et al.
The Journal of Pediatrics|February 5, 2000
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccineR B Belshe, W C Gruber, P M Mendelman, et al.
Pageof 36